Age (years) |
|
Median (min-max) |
59 (34 – 80) |
Hysterectomy procedure |
|
Robotic-assisted vaginal hysterectomy |
30% (9) |
Total abdominal hysterectomy |
23.3% (7) |
Radical hysterectomy |
23.3% (7) |
Laparoscopic-assisted vaginal hysterectomy |
23.3% (7) |
Pelvic lymph node removal |
|
Yes |
96.7% (29) |
No |
3.3% (1) |
Para-aortic lymph node removal |
|
Yes |
63.3% (19) |
No |
36.7% (11) |
Histologic type |
|
Endometrioid endometrial adenocarcinoma |
60% (18) |
Papillary serous adenocarcinoma |
30% (9) |
Clear cell carcinoma |
10% (3) |
Stages |
|
Papillary serous or clear cell adenocarcinoma: |
|
I |
16.7% (5) |
II |
13.3% (4) |
IIIC1 |
10% (3) |
Endometrioid endometrial adenocarcinoma: |
|
II |
6.7% (2) |
IIIA |
16.7% (5) |
IIIB |
3.3% (1) |
IIIC1 |
33.3% (10) |